2021/04/12 ALA-1000 Receive Decision of Grant from Federal Service for Intellectual Property (ROSPATENT) (Application No. 2019102895).Post author:alarpharmPost published:21 . 4 . 2021Post category:Media releases You Might Also Like 2023/07/19 ALA-1300 Received the patent, LONG-ACTING INJECTABLE FORMULATIONS AND CRYSTALLINE FORMS OF BUPRENORPHINE DERIVATIVES , from Directorate General of Intellectual Property Rights (DGIP) of Indonesia, NO IDP 000 087828 B 26 . 7 . 2023 2024/03/14 ALA-3000 has received a notice of allowance from National Office of Intellectual Property of Vietnam (NOIP) after examination. (Patent Application No. 1-2021-03276) 15 . 3 . 2024 2022/08/10 ALA-1000 Received notice of patent allowance from National Institute of Industrial Property Institute (INAPI), Chile , Application No. 624-2019 11 . 8 . 2022 2023/10/12 ALA-2000 has received a notice of allowance from Taiwan Intellectual Property Office (TIPO) after examination. (Patent Application No. 108147847) 29 . 2 . 2024 2022/05/06 ALA-1000 Received notice of patent allowance from Intellectual Property Office of India , Application No. 201947006642 9 . 5 . 2022
2023/07/19 ALA-1300 Received the patent, LONG-ACTING INJECTABLE FORMULATIONS AND CRYSTALLINE FORMS OF BUPRENORPHINE DERIVATIVES , from Directorate General of Intellectual Property Rights (DGIP) of Indonesia, NO IDP 000 087828 B 26 . 7 . 2023
2024/03/14 ALA-3000 has received a notice of allowance from National Office of Intellectual Property of Vietnam (NOIP) after examination. (Patent Application No. 1-2021-03276) 15 . 3 . 2024
2022/08/10 ALA-1000 Received notice of patent allowance from National Institute of Industrial Property Institute (INAPI), Chile , Application No. 624-2019 11 . 8 . 2022
2023/10/12 ALA-2000 has received a notice of allowance from Taiwan Intellectual Property Office (TIPO) after examination. (Patent Application No. 108147847) 29 . 2 . 2024
2022/05/06 ALA-1000 Received notice of patent allowance from Intellectual Property Office of India , Application No. 201947006642 9 . 5 . 2022